Reducing the risk of fractures--the options narrow for cost-effective therapeutic alternatives.

Journal of managed care pharmacy : JMCP

Volumn 10, Issue 2, 2004, Pages 168-179

  Curtiss, Frederic R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

AGED; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; FEMALE; FOOD AND DRUG ADMINISTRATION; FRACTURE; HORMONE SUBSTITUTION; HUMAN; NOTE; OSTEOPOROSIS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; WOMEN'S HEALTH;

AGED; BONE DENSITY; COST-BENEFIT ANALYSIS; DIPHOSPHONATES; DRUG COSTS; FEMALE; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; OSTEOPOROSIS; PATIENT COMPLIANCE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOMEN'S HEALTH;

EID: 2342592006     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)